For example, targeting TRAF3IP2 inhibited IL1b, IL6, IL8, FGF2, EGF, PDGFRB, PGF, VEGFA, VEGFR2, ANGPT2, and ITGAV expression in GBM cells (Figure 4). The gene discussed is KDR; the disease is glioblastoma.